Literature DB >> 19417220

Bile acids: regulation of apoptosis by ursodeoxycholic acid.

Joana D Amaral1, Ricardo J S Viana, Rita M Ramalho, Clifford J Steer, Cecília M P Rodrigues.   

Abstract

Bile acids are a group of molecular species of acidic steroids with peculiar physical-chemical and biological characteristics. At high concentrations they become toxic to mammalian cells, and their presence is pertinent in the pathogenesis of several liver diseases and colon cancer. Bile acid cytoxicity has been related to membrane damage, but also to nondetergent effects, such as oxidative stress and apoptosis. Strikingly, hydrophilic ursodeoxycholic acid (UDCA), and its taurine-conjugated form (TUDCA), show profound cytoprotective properties. Indeed, these molecules have been described as potent inhibitors of classic pathways of apoptosis, although their precise mode of action remains to be clarified. UDCA, originally used for cholesterol gallstone dissolution, is currently considered the first choice therapy for several forms of cholestatic syndromes. However, the beneficial effects of both UDCA and TUDCA have been tested in other experimental pathological conditions with deregulated levels of apoptosis, including neurological disorders, such as Alzheimer's, Parkinson's, and Huntington's diseases. Here, we review the role of bile acids in modulating the apoptosis process, emphasizing the anti-apoptotic effects of UDCA and TUDCA, as well as their potential use as novel and alternate therapeutic agents for the treatment of apoptosis-related diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19417220      PMCID: PMC2724780          DOI: 10.1194/jlr.R900011-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  142 in total

Review 1.  Neurodegeneration: what is it and where are we?

Authors:  Serge Przedborski; Miquel Vila; Vernice Jackson-Lewis
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.

Authors:  Rui E Castro; Joana D Amaral; Susana Solá; Betsy T Kren; Clifford J Steer; Cecília M P Rodrigues
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-04-12       Impact factor: 4.052

3.  Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis.

Authors:  Shuchen Li; Yongge Zhao; Xi He; Tae-Hyoung Kim; Diane K Kuharsky; Hannah Rabinowich; Jun Chen; Chunying Du; Xiao-Ming Yin
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

4.  Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation.

Authors:  C M Rodrigues; X Ma; C Linehan-Stieers; G Fan; B T Kren; C J Steer
Journal:  Cell Death Differ       Date:  1999-09       Impact factor: 15.828

5.  Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1.

Authors:  Thomas Pusl; Timo Vennegeerts; Ralf Wimmer; Gerald U Denk; Ulrich Beuers; Christian Rust
Journal:  Biochem Biophys Res Commun       Date:  2007-12-27       Impact factor: 3.575

6.  Interaction between caspase-8 activation and endoplasmic reticulum stress in glycochenodeoxycholic acid-induced apoptotic HepG2 cells.

Authors:  Toru Iizaka; Mayumi Tsuji; Hideto Oyamada; Yuri Morio; Katsuji Oguchi
Journal:  Toxicology       Date:  2007-09-05       Impact factor: 4.221

Review 7.  Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors.

Authors:  Sagar Sengupta; Bohdan Wasylyk
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

8.  Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease.

Authors:  Wei-Ming Duan; Cecilia M P Rodrigues; Li-Ru Zhao; Clifford J Steer; Walter C Low; Cecilia M P Rodrigures
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

9.  Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids.

Authors:  Bryson W Katona; Carolyn L Cummins; Andrew D Ferguson; Tingting Li; Daniel R Schmidt; David J Mangelsdorf; Douglas F Covey
Journal:  J Med Chem       Date:  2007-10-27       Impact factor: 7.446

10.  Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis.

Authors:  Ronit Vogt Sionov; Orly Cohen; Shlomit Kfir; Yael Zilberman; Eitan Yefenof
Journal:  J Exp Med       Date:  2006-01-03       Impact factor: 14.307

View more
  100 in total

1.  Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.

Authors:  Elaine Studer; Xiqiao Zhou; Renping Zhao; Yun Wang; Kazuaki Takabe; Masayuki Nagahashi; William M Pandak; Paul Dent; Sarah Spiegel; Ruihua Shi; Weiren Xu; Xuyuan Liu; Pat Bohdan; Luyong Zhang; Huiping Zhou; Phillip B Hylemon
Journal:  Hepatology       Date:  2011-11-30       Impact factor: 17.425

2.  Interspecies Chemical Signals Released into the Environment May Create Xenohormetic, Hormetic and Cytostatic Selective Forces that Drive the Ecosystemic Evolution of Longevity Regulation Mechanisms.

Authors:  Michelle T Burstein; Adam Beach; Vincent R Richard; Olivia Koupaki; Alejandra Gomez-Perez; Alexander A Goldberg; Pavlo Kyryakov; Simon D Bourque; Anastasia Glebov; Vladimir I Titorenko
Journal:  Dose Response       Date:  2011-07-27       Impact factor: 2.658

Review 3.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

4.  Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis.

Authors:  Tao Zhang; Wolfgang Baehr; Yingbin Fu
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

Review 5.  Bile acids regulate cardiovascular function.

Authors:  Sandeep Khurana; Jean-Pierre Raufman; Thomas L Pallone
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

Review 6.  Cutting-edge issues in primary biliary cirrhosis.

Authors:  Marco Folci; Francesca Meda; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

7.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

8.  Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells.

Authors:  Simon Hohenester; Anna Gates; Ralf Wimmer; Ulrich Beuers; M Sawkat Anwer; Christian Rust; Cynthia R L Webster
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

9.  Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.

Authors:  Yan-Dong Wang; Wei-Dong Chen; Cunbao Li; Cong Guo; Yanyan Li; Hui Qi; Hailing Shen; Jing Kong; Xuecheng Long; Frank Yuan; Xichun Wang; Wendong Huang
Journal:  Mol Endocrinol       Date:  2014-12-12

10.  Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.

Authors:  Patricia A Thompson; Betsy C Wertheim; Denise J Roe; Erin L Ashbeck; Elizabeth T Jacobs; Peter Lance; María Elena Martínez; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.